CV Sciences OTC Stock Top Insiders
CVSI Stock | USD 0.04 0.00 0.00% |
CV Sciences employs about 69 people. The company is managed by 6 executives with a total tenure of roughly 161 years, averaging almost 26.0 years of service per executive, having 11.5 employees per reported executive. Assessment of CV Sciences' management performance can provide insight into the firm performance.
Joseph Dowling Insider S CEO |
Tim Hitchman Insider VP Operations |
CVSI |
CV Sciences Management Team Effectiveness
The company has return on total asset (ROA) of (0.5182) % which means that it has lost $0.5182 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.36) %, meaning that it created substantial loss on money invested by shareholders. CV Sciences' management efficiency ratios could be used to measure how well CV Sciences manages its routine affairs as well as how well it operates its assets and liabilities.CV Sciences Workforce Comparison
CV Sciences is number one stock in number of employees category among its peers. The total workforce of Consumer Staples industry is currently estimated at about 680. CV Sciences retains roughly 69.0 in number of employees claiming about 10% of stocks in Consumer Staples industry.
The company has Profit Margin (PM) of (0.85) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.93) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.93. CV Sciences Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. CV Sciences Price Series Summation is a cross summation of CV Sciences price series and its benchmark/peer.
CV Sciences Notable Stakeholders
A CV Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CV Sciences often face trade-offs trying to please all of them. CV Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CV Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Joseph Dowling | S CEO | Profile | |
Tim Hitchman | VP Operations | Profile | |
Jesse Karagianes | VP Growth | Profile | |
Joerg Grasser | Chief Officer | Profile | |
Stuart Tomc | VP Nutrition | Profile | |
Alyssa Dunn | Operations Mang | Profile |
About CV Sciences Management Performance
The success or failure of an entity such as CV Sciences often depends on how effective the management is. CV Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CVSI management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CVSI management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
CV Sciences, Inc. operates as a life science company in North America. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California. Cv Sciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 69 people.
The data published in CV Sciences' official financial statements typically reflect CV Sciences' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving CV Sciences' quantitative information. For example, before you start analyzing numbers published by CVSI accountants, it's essential to understand CV Sciences' liquidity, profitability, and earnings quality within the context of the Personal Products space in which it operates.
CV Sciences Workforce Analysis
Traditionally, organizations such as CV Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CV Sciences within its industry.CV Sciences Manpower Efficiency
Return on CV Sciences Manpower
Revenue Per Employee | 290.6K | |
Revenue Per Executive | 3.3M | |
Net Loss Per Employee | 225.4K | |
Net Loss Per Executive | 2.6M | |
Working Capital Per Employee | 186K | |
Working Capital Per Executive | 2.1M |
Complementary Tools for CVSI OTC Stock analysis
When running CV Sciences' price analysis, check to measure CV Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CV Sciences is operating at the current time. Most of CV Sciences' value examination focuses on studying past and present price action to predict the probability of CV Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CV Sciences' price. Additionally, you may evaluate how the addition of CV Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Stocks Directory Find actively traded stocks across global markets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |